Thirty-years of screening for cystic fibrosis in East Anglia

Archives of Disease in Childhood

Volumn 97, Issue 12, 2012, Pages 1043-1047

  Calvin, Jacqui ^a   Hogg, Sarah L ^a   McShane, Donna ^a   McAuley, Sharon Anne ^a   Iles, Richard ^a   Ross Russell, Robert ^a   MacLean, Fiona M ^b   Heeley, Mary E ^c   Heeley, Anthony F ^c  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c PETERBOROUGH DISTRICT HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TRYPSINOGEN;

ARTICLE; CYSTIC FIBROSIS; DNA DETERMINATION; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MECONIUM ILEUS; NEWBORN; NEWBORN SCREENING; PANCREAS INSUFFICIENCY; PREDICTIVE VALUE; PRIORITY JOURNAL;

CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DNA; DNA MUTATIONAL ANALYSIS; GENETIC TESTING; HUMANS; INCIDENCE; INFANT, NEWBORN; MUTATION; NEONATAL SCREENING; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TRYPSINOGEN;

EID: 84869886284     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/archdischild-2012-301968     Document Type: Article

References (22)

1. Heeley AF, Heeley ME, King DN, et al. Screening for cystic fibrosis by dried blood spot assay. Arch Dis Child 1982;57:18-21.
2. Crossley JR, Elliott RB, Smith PA. Dried blood spot screening for cystic fibrosis in the newborn. Lancet 1979;1:472-4.
3. Pollitt RJ, Dalton A, Evans S, et al. Neonatal screening for cystic fibrosis in the Trent region (UK): two stage immunoreactive trypsin screening compared with a three-stage protocol with DNA as an equivocal step. J Med Screen 1997;4:23-8.
4. UK Newborn Screening Programme Centre (online). http://newbornbloodspot. screening.nhs.uk/ (accessed 26 Oct 2011).
5. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998;17:857-72.
6. Fitzgerald D, Van Aspern P, Henry R, et al. Delayed diagnosis of cystic fibrosis in children with a rare genotype (DF508/R117H). J Paediatr Child Health 1995;31:168-71.
7. Stewart B, Zabner J, Shuber AP, et al. Normal sweat chlorides do not exclude the diagnosis of cystic fibrosis. Am J Respir Crit Care Med 1995;151:899-903.
8. Massie J, Clements B, the Australian Paediatric Respiratory Group. Diagnosis of cystic fibrosis after newborn screening: The Australian Experience - Twenty years and five million babies later: a consensus statement from the Australasian Paediatric Respiratory Group. Pediatr Pulmonol 2005;39:440-6.
9. King A, Mueller RF, Heeley AF, et al. Diagnosis of cystic fibrosis in premature infants. Ped Res 1986;20:536-41.
10. Heeley AF, Bangert SK. The neonatal detection of cystic fibrosis by measurement of immunoreactive trypsin in blood. Ann Clin Biochem 1992;29:361-76.
11. Elliott RB. Newborn screening for cystic fibrosis: a historical perspective. Pediatr Pulmonol (suppl) 1991;7:7-10.
12. Sontag MK, Hammond KB, Zielenski J, et al. Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficiency and diagnostic outcomes. J Pediatr 2005;147(Suppl 3):S83-88.
13. Massie RJ, Curnow L, Glasner J, et al. Lessons learned from 20 years of newborn screening for cystic fibrosis. MJA 2012;196:67-70.
14. Therrell BL Jr, Hannon WH, Hoffman G, et al. Immunoreactive trypsinogen (IRT) as a biomarker for cystic fibrosis: challenges in newborn blood spot screening. Mol Gen Metab 2012;106:1-6.
15. Heeley AF, Fagan DH. Trisomy 18, cystic fibrosis, and blood immunoreactive trypsin. Lancet 1984;1:169-70.
16. Priest FJ, Nevin NC. False positive results with immunoreactive trypsinogen screening for cystic fibrosis owing to trisomy 13. J Med Genetics 1991;28:575-6.
17. Oosterveld MJ, Schilperoort JV, Lilien MR, et al. Positive neonatal screening for cystic fibrosis in neonates with renal failure. Thorax 2010;65:652-3.
18. Calvin J, Poyser KH, Heeley M, et al. Raised immunoreactive trypsin in metabolic disease other than cystic fibrosis. J Inherit Met Dis 2000;23(suppl 1):284.
19. Ravine D, Francis RI, Danks DM. Non-specific elevation of immunoreactive trypsinogen in sick infants. Eur J Pediatr 1993;152:348-9.
20. Lindau-Shepard BA, Pass KA. Newborn screening for cystic fibrosis by use of a multiplex immunoassay. Clin Chem 2010;56:445-50.
21. Heeley ME, Travert G, Ferre C, et al. The international quality assurance program for the assay of immunoreactive trypsin in dried blood spots. Pediatr Pulmonol Suppl 1991;7:72-5.
22. Mayell SJ, Munck A, Craig JV, et al., on behalf of the European cystic fibrosis society neonatal screening working group. A European Consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis. J Cystic Fibrosis 2009;8:71-8.